When was Kino Biotech founded?

Kino Biotech was founded in 2010.

Where is Kino Biotech located?

Kino Biotech is headquartered in Singapore, Singapore.

How many employees does Kino Biotech have?

As of Jun 30, 2026, the latest employee count at Kino Biotech is 68.

Is Kino Biotech a funded company?

Kino Biotech is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Kino Biotech rank among its competitors?

Kino Biotech ranks 9th amongst 84 active competitors, of which 2 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Elmed Probiotics, which secured $2.7M in Mar, 2026.

Who are the top competitors of Kino Biotech?

Kino Biotech's top competitors include Natural Alternatives International, Xymogen and Robinson Pharma. Among them, Elmed Probiotics secured the most recent funding round in March, 2026.

Kino Biotech - 2026 Company Profile, Team & Competitors

Company Details

Manufacturer of health supplements, pharmaceuticals, and contract manufacturer of capsules and tablets. It develops and produces a range of consumer health products, including dietary supplements and pharmaceuticals. A significant part of its business involves providing contract manufacturing services, specializing in the production of seamless capsules and tablets for other companies. The company also offers functional materials for sale. Its operations encompass research and development, focusing on areas such as gut health and related scientific advancements.

Website: www.kinobiotech.com/
Email ID: *****@kinobiotech.com

Key Metrics

Founded Year

2010

Location

Singapore, Singapore

Stage

Public

Ranked

9^th among 84 active competitors

Employee Count

68 as on Jun 30, 2026

Similar Companies

Natural Alternatives International & 87 more

Exit Details

Public

View Kino Biotech's full profile

Kino Biotech got listed on Dec 28, 2011.

Click here to take a look at Kino Biotech's IPO in detail

Kino Biotech is a funded company.

Kino Biotech's employee count trend

Kino Biotech has 68 employees as of Jun 26. Here is Kino Biotech's employee count trend over the years:

Uncover Kino Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Kino Biotech include Natural Alternatives International, Xymogen and Robinson Pharma. Here is the list of Top 10 competitors of Kino Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Natural Alternatives International 1980, San Marcos (United States), Public	Manufacturer of customized nutritional supplements	-	-	54/100
2nd	Xymogen 1991, Orlando (United States), Series B	Premium dietary supplements for health and wellness, trusted by professionals	$7.36M	-	52/100
3rd	Robinson Pharma 1989, Santa Ana (United States), Unfunded	Manufacturer of supplements offering contract manufacturing, private labeling, and custom formulation	-	-	50/100
4th	DFE Pharma 2011, Goch (Germany), Acquired	Developer and manufacturer of excipients for oral solid dosage forms and dry powder inhalations	-	FrieslandCampina	47/100
5th	Elmed Probiotics 2018, Hyderabad (India), Series A	Manufacturer of nutritional supplements and probiotics	$2.7M	NABVENTURES	45/100
6th	ELMED Probiotics 2018, Hyderabad (India), Unfunded	Manufacturer of probiotic solutions for human, animal, and agricultural health	-	-	42/100
7th	Scicore 2020, Ahmedabad (India), Unfunded	Manufacturer of nutraceuticals, dietary supplements, sports nutrition, and functional foods	-	-	40/100
8th	Advenza 2005, Thane (India), Unfunded	Manufacturer of enzyme and custom probiotics solutions	-	-	39/100
9th	Kino Biotech 2010, Singapore (Singapore), Public	Manufacturer of health supplements, pharmaceuticals, and contract manufacturer of capsules and tablets	-	-	37/100
10th	Rhetthealthcare 2018, Secunderabad (India), Unfunded	Manufacturer of nutraceutical, ayurceutical, and cosmeceutical products	-	-	37/100